Catheter ablation was not the first-line treatment for supraventricular tachycardia (SVT) for most patients referred to a tertiary center, a study shows, with investigators suggesting the procedure is ...
PARIS — Catheter ablation has been placed front and center in the latest guidelines for the management of supraventricular tachycardia (SVT) from the European Society of Cardiology (ESC). The ...
Interim results highlight six-month outcomes for patients treated with the Sphere-9 catheter for sustained monomorphic ventricular tachycardia (VT)Breakthrough device designation granted for use of th ...
Proton beam therapy, a radiation treatment for cancer, may be effective as a treatment for refractory ventricular tachycardia ...
A first-in-human study suggests proton beam therapy, a cancer treatment, could sharply reduce ventricular tachycardia episodes in patients unresponsive to drugs or catheter ablation. The noninvasive ...
SAN FRANCISCO -- Noninvasive stereotactic radiotherapy (RT) for refractory ventricular tachycardia (VT) achieved outcomes similar to catheter ablation with substantially fewer serious adverse events ...
Initial strategy of catheter ablation leads to lower risk for composite primary end point versus antiarrhythmic drug therapy. (HealthDay News) — An initial strategy of catheter ablation leads to a ...
Patients with structural heart disease are at risk for life-threatening ventricular tachycardias (VTs). Implantable cardioverter-defibrillators (ICDs) can terminate VT, but often at the cost of ...
CHICAGO -- For patients with ventricular tachycardia (VT) and ischemic cardiomyopathy, going right to catheter ablation improved outcomes compared with trying antiarrhythmic drugs first, the VANISH2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results